Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 1726 AL 1740

Cognitive Changes and Promotion in Parkinson's Disease

Wang X, Wang X, Chen H, Canning SD, Luo X.

Parkinsons Dis. 2018 Aug 1;2018:9872183. doi: 10.1155/2018/9872183. eCollection 2018.

Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease

Palfi S, Gurruchaga JM, Lepetit H, Howard K, Ralph GS, Mason S, Gouello G, Domenech P, Buttery PC, Hantraye P, Tuckwell NJ, Barker RA, Mitrophanous KA.

Hum Gene Ther Clin Dev. 2018 Sep;29(3):148-155. doi: 10.1089/humc.2018.081.

Focused ultrasound thalamotomy in Parkinson disease: Nonmotor outcomes and quality of life

Sperling SA, Shah BB, Barrett MJ, Bond AE, Huss DS, Gonzalez Mejia JA, Elias WJ.

Neurology. 2018 Oct 2;91(14):e1275-e1284. doi: 10.1212/WNL.0000000000006279. Epub 2018 Aug 29.

Schizophrenia as Potential Trigger for Melanoma Development and Progression! The Psycho-Neuro-Endocrine-Oncology (P.N.E.O) Network!

Tchernev G, Lozev I, Temelkova I, Chernin S, Yungareva I.

Open Access Maced J Med Sci. 2018 Aug 16;6(8):1442-1445. doi: 10.3889/oamjms.2018.276. eCollection 2018 Aug 20.

The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases

Bagatini MD, Dos Santos AA, Cardoso AM, Mânica A, Reschke CR, Carvalho FB.

J Immunol Res. 2018 Aug 12;2018:4892473. doi: 10.1155/2018/4892473. eCollection 2018.

REM sleep behaviour disorder

Dauvilliers Y, Schenck CH, Postuma RB, Iranzo A, Luppi PH, Plazzi G, Montplaisir J, Boeve B.

Nat Rev Dis Primers. 2018 Aug 30;4(1):19. doi: 10.1038/s41572-018-0016-5.

Structural neuroimaging as clinical predictor: A review of machine learning applications

Mateos-Pérez JM, Dadar M, Lacalle-Aurioles M, Iturria-Medina Y, Zeighami Y, Evans AC.

Neuroimage Clin. 2018 Aug 10;20:506-522. doi: 10.1016/j.nicl.2018.08.019. eCollection 2018.

The long-term efficacy of STN vs GPi deep brain stimulation for Parkinson disease: A meta-analysis

Peng L, Fu J, Ming Y, Zeng S, He H, Chen L.

Medicine (Baltimore). 2018 Aug;97(35):e12153. doi: 10.1097/MD.0000000000012153.

Neurofilaments as biomarkers in neurological disorders

Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, Barro C, Kappos L, Comabella M, Fazekas F, Petzold A, Blennow K, Zetterberg H, Kuhle J.

Nat Rev Neurol. 2018 Oct;14(10):577-589. doi: 10.1038/s41582-018-0058-z.

A natural history of skills

Boraud T, Leblois A, Rougier NP.

Prog Neurobiol. 2018 Dec;171:114-124. doi: 10.1016/j.pneurobio.2018.08.003. Epub 2018 Aug 29.

Non-cell-autonomous actions of α-synuclein: Implications in glial synucleinopathies

Lim S, Kim HJ, Kim DK, Lee SJ.

Prog Neurobiol. 2018 Oct;169:158-171. doi: 10.1016/j.pneurobio.2018.06.010. Epub 2018 Jul 3.

Neuroscience learning from longitudinal cohort studies of Alzheimer's disease: Lessons for disease-modifying drug programs and an introduction to the Center for Neurodegeneration and Translational Neuroscience

Miller JB, Cummings J, Nance C, Ritter A.

Alzheimers Dement (N Y). 2018 Jul 11;4:350-356. doi: 10.1016/j.trci.2018.06.006. eCollection 2018.

[FROM GENETICS OF FRAGILE X SYNDROME TO DEVELOPMENT OF TARGETED AND PERSONALIZED DRUG THERAPY]

Gabis LV, Shefer S, Gruber N, Raviv R, Cohen Y, Berkenstadt M, Ries-Levavi L, Pinhas-Hamiel O, Elizur S.

Harefuah. 2018 Aug;157(8):529-533.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias